Daewoong Pharmaceutical Co., Ltd

₩103,200As of Sun 8 Nov 2026, 12:00 UTC
KRX:069620Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR 4.68%
Div yield 0.58%
ROE 16.64%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.01
PE TTM 6.075
TSR TTM (25.71%)
Mkt cap ₩1.187T
ROIC 9.78%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩98,710
(4.35%)
(92.49%)
Hold 6|7|8|0|4
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
2,217
2,292
2,307
2,298
20.41%
16.84%
15.23%
12.59%
Revenue₩B
79.52
79.02
78.07
81.88
4.82%
4.80%
2.77%
6.37%
Peers (US$875.5M)
Cap (US$)
PE
1.179B
—
612.0M
10.54x
872.1M
978.4x
Capital
TTM
5Y
10Y
Leveragex
1.882
0.071
0.068
EBIT/Intx
0.421
0.307
0.326
Own earn%
(3.37)
8.19
8.41
Sh yield%
37.63
23.49
22.85
Owners
Insiders/Inst%
10.89
54.94
Short interest%
5.69
SBC / revenue%
3.55
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
5–13
$1 testx
−0.1
Incr. ROIC%
7